NPI: 1790759744 · INGLEWOOD, CA 90303 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/15/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/15/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| DVA RENAL HEALTHCARE INC | SELLS | AZ | $7.17M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,244 | $1.93M |
| 2019 | 5,335 | $417K |
| 2020 | 7,155 | $596K |
| 2021 | 11,151 | $944K |
| 2022 | 6,968 | $1.03M |
| 2023 | 7,765 | $1.50M |
| 2024 | 9,119 | $1.35M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 30,982 | 3,279 | $5.10M | |
| 0821 | 1,943 | 696 | $2.38M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,989 | 1,005 | $145K |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,026 | 755 | $95K |
| J1756 | Injection, iron sucrose, 1 mg | 3,456 | 1,323 | $20K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,008 | 549 | $17K |
| A4657 | Syringe, with or without needle, each | 2,536 | 1,278 | $12K |
| 0250 | 1,537 | 95 | $4K | |
| 82728 | 433 | 421 | $1K | |
| 83970 | 880 | 871 | $976.61 | |
| 83550 | 397 | 385 | $849.25 | |
| 83540 | 443 | 429 | $634.80 | |
| 85041 | 1,009 | 996 | $436.00 | |
| 82108 | 39 | 39 | $404.78 | |
| 85048 | 1,028 | 1,013 | $374.87 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 13 | 12 | $164.00 |
| 0302 | 18 | 12 | $0.00 |